1095-急性髓系白血病细胞亚型对维奈克拉耐药性的决定作用 episode artwork

EPISODE · Jun 7, 2026 · 23 MIN

1095-急性髓系白血病细胞亚型对维奈克拉耐药性的决定作用

from 聊聊Sci

这项研究揭示了急性髓系白血病(AML)中存在四种不同的白血病干细胞(LSC)亚型,这些亚型决定了患者对药物维奈克拉(venetoclax)的耐药性。研究人员通过对超过150名患者的分子谱分析发现,LAMP5+单核/树突状(MoDe)干细胞是导致耐药的关键因素之一。此外,白血病干细胞具有可塑性,能够向巨核/红系(MEP)状态转变,从而避开药物攻击。针对这些特定的脆弱点,研究建议使用MEK1/2抑制剂针对MoDe型细胞,或使用BCL-xL抑制剂针对MEP型细胞。这种基于生物标志物的分类方法为克服AML耐药性提供了精准的靶向治疗策略。References:Waclawiczek A, Leppä A M, Renders S, et al. Leukemic stem cell subtypes determine venetoclax resistance and therapeutic vulnerabilities in AML[J]. Cell stem cell, 2026.前往小宇宙评论区与主播互动

Episode metadata supplied by the publisher feed · Published Jun 7, 2026

Embed this episode

Ready to play

1095-急性髓系白血病细胞亚型对维奈克拉耐药性的决定作用

0:00 23:01

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of 聊聊Sci?

This episode is 23 minutes long.

When was this 聊聊Sci episode published?

This episode was published on June 7, 2026.

Can I download this 聊聊Sci episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!